View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 09, 2022
2 min read
Save

Survey: 20% of women with high deductible would forgo testing after abnormal mammogram

Survey: 20% of women with high deductible would forgo testing after abnormal mammogram

One in five women with high-deductible health insurance plans who had an abnormal screening mammogram would opt out of follow-up testing, according to survey results presented at the Radiological Society of North America annual meeting.

SPONSORED CONTENT
December 09, 2022
2 min read
Save

Cervical cancer screening decreased among older women but may remain higher than needed

Cervical cancer screening decreased among older women but may remain higher than needed

Despite decreases in cervical cancer screenings between 1999 and 2019 among older women with Medicare fee-for-service coverage, this group may be overspending on screening-related services, according to data in JAMA Internal Medicine.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
December 08, 2022
1 min read
Save

Top in hem/onc: Alcohol and cancer risk unawareness; professional wellness

Top in hem/onc: Alcohol and cancer risk unawareness; professional wellness

Although data show a clear link between alcohol consumption and an increased risk for certain cancers, a high percentage of adults in the United States were unaware of the association, according to recent study results.

SPONSORED CONTENT
December 08, 2022
10 min listen
Save

Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of December 5, 2022

Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of December 5, 2022

In this edition, fludarabine has been placed on the FDA’s drug shortage list; epcoritamab is approved for advanced lymphoma; pembrolizumab with chemotherapy improves OS in gastric cancer, and more.

SPONSORED CONTENT
December 06, 2022
1 min read
Save

Cancer risk similar in patients treated with TNF inhibitors, other targeted therapies

Cancer risk similar in patients treated with TNF inhibitors, other targeted therapies

PHILADELPHIA — Patients with rheumatic diseases and previous malignancy do not demonstrate a higher cancer risk with TNF inhibitors vs. other biologic and targeted synthetic DMARDs, according to data presented at ACR Convergence 2022.

SPONSORED CONTENT
December 01, 2022
1 min read
Save

Top in hem/onc: Molecular testing in lung cancer; gender disparities in NIH funding

Top in hem/onc: Molecular testing in lung cancer; gender disparities in NIH funding

Despite its benefits, data suggest that comprehensive molecular testing in patients with non-small cell lung cancer is underutilized due to a lack of resources.

SPONSORED CONTENT
November 30, 2022
13 min listen
Save

Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of November 28, 2022

Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of November 28, 2022

In this edition, disparities among women in the surgical workforce, GSK withdraws belantamab mafodotin from US market, risk for lymphoma low after postmastectomy reconstruction, and more.

SPONSORED CONTENT
November 30, 2022
35 min listen
Save

Developing Plans for Patient and Trainee Education with Daniel Golden, MD

Developing Plans for Patient and Trainee Education with Daniel Golden, MD

In this episode, host Shikha Jain, MD, speaks with Daniel Golden, MD, about how he has developed educational tools for patients and students, the importance of embracing your niche in medicine and more.

SPONSORED CONTENT
November 24, 2022
11 min listen
Save

Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of November 21, 2022

Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of November 21, 2022

In this edition, lung cancer screening critically low across the U.S, first in-human CRISPR test with gene replacement, racial and economic segregation linked to higher cancer mortality rates, and more.

SPONSORED CONTENT
November 22, 2022
3 min read
Save

Q&A: ‘Promising’ immunotherapies may treat platinum-resistant ovarian cancer

Q&A: ‘Promising’ immunotherapies may treat platinum-resistant ovarian cancer

During their lifetime, one in 70 women will receive a diagnosis of ovarian cancer, which is the second most common gynecologic cancer in the United States, according to Memorial Sloan Kettering Cancer Center.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails